Summary

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published: February 07, 2011
doi:

Summary

The hyperinsulinemic-euglycemic clamp is the “gold standard” for the assessment of insulin action. Insulin is infused at a constant rate stimulating glucose uptake. The amount of exogenous glucose infused to counter this drop is indicative of insulin sensitivity. Here the procedure is performed on a conscious, unrestrained rat.

Abstract

Type 2 diabetes (T2D) is rapidly rising in prevalence. Characterized by either inadequate insulin production or the inability to utilize insulin produced, T2D results in elevated blood glucose levels. The “gold-standard” in assessing insulin sensitivity is a hyperinsulinemic-euglycemic clamp or insulin clamp. In this procedure, insulin is infused at a constant rate resulting in a drop in blood glucose. To maintain blood glucose at a constant level, exogenous glucose (D50) is infused into the venous circulation. The amount of glucose infused to maintain homeostasis is indicative of insulin sensitivity. Here, we show the basic clamp procedure in the chronically catheterized, unrestrained, conscious rat. This model allows blood to be collected with minimal stress to the animal. Following the induction of anesthesia, a midline incision is made and the left common carotid artery and right jugular vein are catheterized. Inserted catheters are flushed with heparinized saline, then exteriorized and secured. Animals are allowed to recover for 4-5 days prior to experiments, with weight gain monitored daily. Only those animals who regain weight to pre-surgery levels are used for experiments. On the day of the experiment, rats are fasted and connected to pumps containing insulin and D50. Baseline glucose is assessed from the arterial line and used a benchmark throughout the experiment (euglycemia). Following this, insulin is infused at a constant rate into the venous circulation. To match the drop in blood glucose, D50 is infused. If the rate of D50 infusion is greater than the rate of uptake, a rise in glucose will occur. Similarly, if the rate is insufficient to match whole body glucose uptake, a drop will occur. Titration of glucose continues until stable glucose readings are achieved. Glucose levels and glucose infusion rates during this stable period are recorded and reported. Results provide an index of whole body insulin sensitivity. The technique can be refined to meet specific experimental requirements. It is further enhanced by the use of radioactive tracers that can determine tissue specific insulin-stimulated glucose uptake as well as whole body glucose turnover.

Protocol

A: Surgical Catheterization of Arterial and Venous Circulation Part 1: Arterial and Venous Catheter Preparation Cut 15 cm of PE-50 (internal diameter of .58mm (.023″) x an outer diameter of .965mm (.038″). Cut a 1mm section of silastic tubing (0.76mm (0.030″) internal diameter x 1.65mm (0.065″) outer diameter) for use as restraining bead. The restraining bead prevents the rat from pulling out the catheter once it is in place. Insert the tips of micro dissecting forceps i…

Discussion

Initially developed for investigation of insulin sensitivity in humans, the clamp procedure has now been adapted to other species including laboratory rats and mice. Investigating animal models of insulin resistance provides a significant aid in understanding the pathophysiology of insulin sensitivity and associated pathologies as well as identifying therapeutic interventions that have clinical value1,2. Several methods to evaluate insulin sensitivity in animals have been employed3. Such techniques …

Divulgations

The authors have nothing to disclose.

Acknowledgements

This study was supported by the Canadian Institutes of Health Research and Genome Canada.JS holds salary support awards from the Alberta Heritage Foundationfor Medical Research, Heart and Stroke Foundation of Canadaand the Canadian Diabetes Association. Special thanks to Dr. David Wasserman and Bingle Bracy for teaching this procedure to the Shearer laboratory.

Materials

Name of the reagent Company Catalogue number Comments (optional)
Intramedic Polyethylene Tubing (PE-50) Fisher Scientific 14-170-12B Internal diameter of .58mm (.023″) x Outer diameter of .965mm (.038″)
Dow Corning Silastic Laboratory Tubing Fisher Scientific 11-189-15C Internal diameter of .76mm (0.030″) x Outer diameter of 1.65mm (0.065″)
Tygon S-50-HL Medical Tubing Harvard Apparatus PY2 72-1251 Internal diameter of 3.2mm (0.125″) x Outer diameter of 4.7mm (0.1875″)
Loctite Super Glue Grand & Toy 32237 Gel Control
Sterile Surgical Blade VWR BD371610  
Curved Micro Dissecting Forceps George Tiemann & Co. 160-20 x 2
Straight Micro Dissecting Forceps George Tiemann & Co. 160-15 x 2
Curved Hemostat George Tiemann & Co. 105-1135 x 2
Straight Hemostat George Tiemann & Co. 105-1130 x 2
Hemostat Tip Guards Robbins Instruments, Inc. 15.09-2-004  
Straight Surgery Scissors George Tiemann & Co. 105-402  
VENOJECT Multi-Sample Luer Adapter Terumo Medical Products 810127A 21 guage, 1 in.
Sterile Catheter Introducer Becton Dickinson 406999  
14-gauge Blunt Needle Becton Dickinson 511310 14 guage, 2 in.
Sterile Surgical Suture Johnson & Johnson Medical Products 1679H Silk, size 3-0
Non-Sterile Surgical Suture Angiotech Pharmaceuticals, Inc. SP116 Silk, size 4-0
Cotton Swabs VWR 10806-005  
4ply Gauze Pads VWR CA43845-062  
Small Animal Cordless Clippers Harvard Apparatus 729063  
Isoflurane Halocarbon Products Corp. IPN-45  
Anesthetic Cart Benson Medical Industries, Inc.    
70 % Ethanol Fisher Scientific HC-1000  
Betadine Antiseptic Solution Western Drug Distribution Centre Ltd. 105267  
Model 11 Plus Syringe Pump Harvard Apparatus 702208  
Stainless Steel Tubing Couplers Harvard Apparatus 72-4434 23 gauge, 0.3 in.
Stainless Steel Tubing Plugs Harvard Apparatus 72-4436 23 gauge, 0.5 in.
Stainless Steel Blunt Needles Instech Laboratories, Inc. LS22 22 gauge
60 Degree Y-Connectors Small Parts STCY-22-05 22 gauge
CritSpin Micro-hematocrit Centrifuge Iris Sample Processing CS12  
Mini Centrifuge Fisher Scientific 05-090-100  
Micro Centrifuge Tubes VWR 53550-778  
50ml polypropylene centrifuge tubes VWR 89004-364  
1ml Plastic Slip Tip Syringes Becton Dickinson 309602  
3ml Plastic Luerlok Tip Syringes Becton Dickinson 309585  
Heparin Anticoagulant Injection Western Drug Distribution Centre Ltd. 102824 Manufacturer: LEO Pharma Inc. Conc. 1000 IU
EDTA Solution Promega Corp. V4231 0.5 M, pH 8.0
Saline Western Drug Distribution Centre Ltd. ABB7983154 Manufacturer: Hospira 0.9% Sodium Chloride
50% Dextrose Vetoquinol 8DEX012D  
Humulin-R Eli Lilly HI-210 100U/ml
1ml Insulin Syringes Becton Dickinson 309311  
Fisherbrand* Hemato-Seal Sealant Fisher Scientific 02-678  
Fisherbrand* Microhematocrit Capillary Tubes Fisher Scientific 22-362-574  
One Touch Ultra Test Strips LifeScan, Inc. AW 085-314H  
One Touch Ultra Blood Glucose Meter LifeScan, Inc. AW 085-314B  
Sodium Pentobarbitol Ceva Sante Animale 1715 138 Conc. 54.7mg/ml
Red Laboratory Labeling Tape VWR 89097-932  
Blue Laboratory Labeling Tape VWR 89097-936  
Weigh Scale Fisher Scientific 01-913-88  
Vortex VWR 58815-234  
Timer VWR 62344-641  

References

  1. Halseth, A. E., Bracy, D. P., Wasserman, D. H. Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Am J Physiol Endocrinol Metab. 279, E1064-E1071 (2000).
  2. Halseth, A. E., Bracy, D. P., Wasserman, D. H. Limitations to muscle glucose uptake due to high fat feeding. Am. J. Physiol. 279, E1064-E1071 (2000).
  3. Muniyappa, R., Lee, S., Chen, H., Quon, M. J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 294, 15-26 (2008).
  4. Cho, H. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 292, 1728-1731 (2001).
  5. Dubois, M. J. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med. 12, 549-556 (2006).
  6. Pacini, G., Thomaseth, K., Ahren, B. Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab. 281, 693-703 (2001).
  7. Herbach, N. Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice. Diabetes. 56, 1268-1276 (2007).
  8. Maeda, N. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 8, 731-737 (2002).
  9. Potenza, M. A., Marasciulo, F. L., Tarquinio, M., Quon, M. J., Montagnani, M. Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance. Diabetes. 55, 3594-3603 (2006).
  10. Ayala, J. E., Bracy, D. P., McGuinness, O. P., Wasserman, D. H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes. 55, 390-397 (2006).
  11. Wasserman, D. H., Ayala, J. E., McGuinness, O. P. Lost in translation. Diabetes. 58, 1947-1950 (2009).
check_url/fr/2432?article_type=t

Play Video

Citer Cet Article
Hughey, C. C., Hittel, D. S., Johnsen, V. L., Shearer, J. Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat. J. Vis. Exp. (48), e2432, doi:10.3791/2432 (2011).

View Video